HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis.

AuthorsLili Luo, Ting Luo, Mengyi Du, Heng Mei, Yu Hu
JournalThe Journal of infection (J Infect) Vol. 84 Issue 3 Pg. 418-467 (03 2022) ISSN: 1532-2742 [Electronic] England
PMID34808242 (Publication Type: Letter, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • tocilizumab
Topics
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Humans
  • SARS-CoV-2
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: